Trendelenburg Marten, Fossati-Jimack Liliane, Cortes-Hernandez Josefina, Turnberg Daniel, Lewis Margarita, Izui Shozo, Cook H Terence, Botto Marina
Rheumatology Section, Imperial College, London, UK.
J Immunol. 2005 Nov 15;175(10):6909-14. doi: 10.4049/jimmunol.175.10.6909.
Many forms of glomerulonephritis are triggered by Ab localization in the glomerulus, but the mechanisms by which this induces glomerular inflammation are not fully understood. In this study we investigated the role of complement in a mouse model of cryoglobulin-induced immune complex glomerulonephritis. Several complement-deficient mice on a C57BL/6 and BALB/c genetic background were used and compared with strain-matched, wild-type controls. Cryoglobulinemia was induced by i.p. injection of 6-19 hybridoma cells producing an IgG3 cryoglobulin with rheumatoid factor activity against IgG2a of allotype a present in BALB/c, but not C57BL/6, mice. Thus, the cryoprecipitate in C57BL/6 mice consisted of the IgG3 cryoglobulin only (type I cryoglobulinemia) compared with IgG3-IgG2a complexes in BALB/c (type II cryoglobulinemia). The survival of mice was not affected by complement deficiency. Glomerular influx of neutrophils was significantly less in C3-, factor B-, and C5-deficient mice compared with wild-type and C1q-deficient mice. It did not correlate with C3 deposition, but did correlate with the amount of C6 deposited. Deficiency of CD59a, the membrane inhibitor of the membrane attack complex, did not induce an increase in neutrophil infiltration, suggesting that the generation of C5a accounts for the effects observed. There was no apparent difference between cryoglobulinemia types I and II regarding the role of complement. Our results suggest that in this model of cryoglobulin-induced glomerulonephritis the neutrophil influx was mediated by C5 activation with the alternative pathway playing a prominent role in its cleavage. Thus, blocking C5 is a potential therapeutic strategy for preventing renal injury in cryoglobulinemia.
许多形式的肾小球肾炎是由抗体在肾小球中的定位引发的,但这种定位诱导肾小球炎症的机制尚未完全明确。在本研究中,我们在冷球蛋白诱导的免疫复合物性肾小球肾炎小鼠模型中研究了补体的作用。使用了几种在C57BL/6和BALB/c遗传背景下的补体缺陷小鼠,并与同品系的野生型对照进行比较。通过腹腔注射6-19杂交瘤细胞诱导冷球蛋白血症,该杂交瘤细胞产生具有针对BALB/c小鼠(而非C57BL/6小鼠)中同种异型a的IgG2a的类风湿因子活性的IgG3冷球蛋白。因此,与BALB/c中的IgG3-IgG2a复合物(II型冷球蛋白血症)相比,C57BL/6小鼠中的冷沉淀物仅由IgG3冷球蛋白组成(I型冷球蛋白血症)。小鼠的存活率不受补体缺陷的影响。与野生型和C1q缺陷小鼠相比,C3、因子B和C5缺陷小鼠中嗜中性粒细胞的肾小球内流明显减少。它与C3沉积无关,但与C6沉积量相关。膜攻击复合物的膜抑制剂CD59a的缺陷并未导致嗜中性粒细胞浸润增加,这表明C5a的产生是观察到的效应的原因。关于补体的作用,I型和II型冷球蛋白血症之间没有明显差异。我们的结果表明,在这种冷球蛋白诱导的肾小球肾炎模型中,嗜中性粒细胞内流是由C5激活介导的,替代途径在其裂解中起主要作用。因此,阻断C5是预防冷球蛋白血症肾损伤的一种潜在治疗策略。